12 patients with pemphigus foliaceus, a form of pemphigus with lesions that arise in the intercellular substance in the superficial layers of the epidermis, and 7 patients with pemphigus vulgaris, where lesions are in the deep layers, were studied by immunofluorescence. Circulating antibodies to intercellular antigens (IC antibodies) were found in 11 pemphigus foliaceus and 5 pemphigus vulgaris patients. On direct immunofluorescence of skin lesions 75% (9 of 12), pemphigus foliaceus patients had intercellular deposits of IgG localized solely or predominantly in the superficial epidermal layers, whereas this was not the case in any of the patients with pemphigus vulgaris. Over 70% of the pemphigus foliaceus patients with predominantly superficial IgG deposits lacked in their lesions normal intercellular antigens usually expressed in the deep layers of the epidermis. This was shown by the inability of IC antibodies in autologous or allogeneic sera to bind to intercellular antigens in the lower epidermis of patient's skin, even though the same sera could bind to intercellular antigens in all layers of normal allogeneic skin. Lack of normal intercellular antigens deep in the epidermis may result in circulating IC antibodies binding to the superficial layers, a site which corresponds to, and thus in some patients may account for, the anatomical location of lesions in pemphigus foliaceus.
A B S T R A C T 12 patients with pemphigus foliaceus, a form of pemphigus with lesions that arise in the intercellular substance in the superficial layers of the epidermis, and 7 patients with pemphigus vulgaris, where lesions are in the deep layers, were studied by immunofluoreseence. Circulating antibodies to intercellular antigens (IC antibodies) were found in 11 pemphigtus foliaceus and 5 pemphigus vulgaris patients. On direct immunofluorescence of skin lesions 75% (9 of 12), pemphigus foliaceus patients had intercellular deposits of IgG localized solely or predominantly in the superficial epidermal layers, whereas this was not the case in any ofthe patients with pemphigus vulgaris. Over 70% of the pemphigus foliaceuis patients with predominantly superficial IgG deposits lacked in their lesions normal intercellular antigens usually expressed in the deep layers of the epidermis. This was shown by the inability of IC antibodies in autologous or allogeneic sera to bind to intercellular antigens in the lower epidermis of patient's skin, even though the same sera could bind to intercellular antigens in all layers of normal allogeneic skin. Lack of normal intercellular antigens deep in the epidermis may result in circulating IC antibodies binding to the superficial layers, a site which corresponds to, and thus in some patients may account for, the anatonmical location of lesions in pemphigus foliaceus.
INTRODUCTION
Pemphigus is an uincomnmoni bullouis eruption of the skin characterized by recurrent painful blisters aind erosions in the oral cavity and skin. Untreated, the disease is usually fatal. There are several forms of pemplhigus which are differentiated principally by the level of lesions in the epidermis. The most common form of pemphigus, pemphigus vulgaris, is characterized by bullae which arise deep in the epidermis just Receivedfor publication 29 April 1977 atd in revisedfornm 26 September 1977. above the basal cell layer. In pemphigus foliaceus, in contrast, the lesions arise in the superficial epidermis. In all forms of pemphigus, the site of the earliest defect visualizable by electron microscopy is in the intercellular (IC)' substance (1, 2) .
Pemphigus is associated with a unique immunologic abnormality. More than 80% of patients with this disease develop intercellular antibodies (3) (4) (5) (6) (7) (8) (9) to antigens which are normal constituents of the intercellular substance in human and mammalian epidermis (10, 11) . Immunoglobulins (4, (12) (13) (14) together with complement (13, 15) are deposited in vivo in the intercellular substance of lesions and normal skin of patients with pemphigus. The correlation between the anatomical position of intercellular antigens and the earliest histological lesions ofpemphigus, and between the titer of IC antibodies and the severity of the disease (5, (16) (17) (18) , suggests that IC antibodies play a role in the pathogenesis of the disease. The production of intraepidermal acantholytic bullae similar to those of pemphigus by IC antibodies incubated with human epidermis in organ culture (19) or repeatedly injected into the skin (20) or oral mucosa (21) Immunofluorescence studies. Indirect immunofluorescence was used to test sera for IC antibodies. The tests were performed by a standard technique (11), as previously described (24) . Briefly, 0.2 ml of the appropriate dilution of human serum in PBS was incubated for 30 min at 27°C with cryostat-cut sections of frozen normal allogeneic skin and monkey and guinea pig esophagus. After washing for 10 min in PBS, the specimens were reincubated with 0.2 ml of the appropriate dilution of fluorescein-labeled conjugate for 30 min at 27°C, washed for 45 min in PBS, and covered with 0.2 ml of mounting medium (90% glycerol in PBS). The slides were examined with a binocular microscope equipped with a mercury vapor lamp and FITC and No. 50 barrier filters. Direct immunofluorescence tests for in vivo deposits of Ig and C3 were performed by established methods (11) .
The presence of intercellular antigens in skin specimens was determined by indirect immunofluorescence. For this purpose, the specimens were reacted with pemphigus vulgaris sera known to have antibodies to intercellular antigens in all epidermal layers. The titer of IC antibodies in these sera ranged from 320 to above 1,280. For use, all sera were diluted 1/20 in PBS.
In vitro complement binding. The ability of antibodies in pemphigus sera to fix complement when bound to intercellular antigens in human skin was tested by a complement binding technique described by Jordon et al. (25) . Briefly, undiluted and 1/5 dilution of patients' sera in PBS were incubated for 30 min at 27°C on cryostat-cut sections of frozen normal allogeneic skin. Each section was washed five times with PBS and incubated for 30 min with a 1/10 dilution of fresh normal human serum in PBS as a complement source. The sections were washed five times in PBS and incubated with fluorescein-labeled conjugate to human C3 for 30 min.
Thereafter, the slides were washed and read as described above for immunofluorescence studies.
RESULTS
Indirect immunofluorescence. During the acute phase of their illness, 11 of the 12 patients with pemphigus foliaceus had in their sera IC antibodies to monkey and (or) guinea pig esophagus. The titers ranged from 80 to above 1, 280 (Table I) Table II , the deposits were predomi- IgG deposits were present in lesions of six of seven patients with this form of pemphigus. In two patients the deposits were only in the deep epidermis, and in the other four they were present throughout the epidermis (see Fig. 2 ). Intercellular IgM deposits were found in one pemphigus foliaceus patient and in none of those with pemphigus vulgaris. In this patient, the deposits were superficial. There were no IgA deposits in any patients. Intercellular deposits of C3 were present in lesions of 10 of 12 (83%) of the patients with pemphigus foliaceus and in 4 of 7 (57%) of those with pemphigus vulgaris. In both diseases, the deposits were predominantly in the deep layer of the epidermis. They were exclusively in this area in six of the pemphigus foliaceus patients and heaviest in this area in another two. Thus, in 80% of the pemphigus foliaceus patients, C3 was deposited predominantly in the deep epidermis. As implicated by these findings, there was no correlation between the site of IgG and C3 deposits. Table IV ). Autologous IC antibodies were unable to bind to the lower epidermis in four of five (80%) patients (Figs. lB and 3A) . The remaining two patients were not studied because they lacked IC antibodies. One patient (3842) lacked deep intercellular antigens reactive to autologous but not to allogeneic IC antibodies (see Figs. 3A-C) whereas the converse was true in another patient (4306). In all cases, IC antibodies in pemphigus foliaceus and pemphigus vulgaris sera were able to bind to intercellular antigens in the lower layers of normal allogeneic epidermis (see Tables III and IV, Expression of deep intercellular antigens in uninvolved skin of patients with pemphigus foliaceuis. To determine whether the loss of intercellular antigens in pemphigus foliaceus was restricted to lesions or was a more general phenomenon, we examined uninvolved skin in five patients for in vivo deposits of IgG and for the presence of intercellular antigens in the lower epidermis. As can be seen in Table V , intercellular deposits of IgG were present in uninvolved skin in three of five (22) . In the present study, subcorneal IC antibodies were found in only 1 of 12 patients. The antibodies in the other patients were capable of reacting to intercellular antigens in all layers of normal allogeneic or xenogeneic stratified squamous epithelium, thus excluding this possibility from consideration. The second possibility was that some normal intercellular antigens were not expressed in the lower epidermis ofthe patients. This appeared to be the case in several patients, as evidenced by the inability of autologous or allogeneic IC antibodies to bind to the intercellular substance in deep layers of their epidermis. This was due to a lack of intercellular antigens normally expressed in this location, since the same sera could bind to deep intercellular antigens in normal allogeneic skin. It was unlikely that C3 or other classes of immunoglobulin bound in vivo to deep intercellular antigens were preventing other antibodies from binding to the same site, leading to an erroneous interpretation of antigen loss. None of the five patients lacking deep IC antigens had in vivo deposits of IgG, IgM, or IgA in this location, and in two patients C3 was absent as well. Furthermore, in the cases which could be studied, intercellular deposits of C3 did not block the subsequent binding of IC antibodies to the same sites. IgE and IgD were not looked for, since no abnormal deposits of these classes of immunoglobulin have been reported in pemphigus. Overall, deep intercellular antigens reactive to autologous sera were not expressed in lesions of 33% of the pemphigus foliaceus patients and in 80% of those lacking deep intercellular deposits of IgG in vivo.
The causes of antigen loss were not determined. It was more common in lesions than in uninvolved skin of the same patient. While possibly due to tissue damage resulting from the disease, this was unlikely to be the sole explanation, since intercellular antigens were retained in the superficial layers of the epidermis at sites of greatest tissue damage. Furthermore, deep intercellular antigens were absent in the uninvolved skin of at least one patient. The predominant association of antigen loss with skin lesions suggests the intriguing possibility that regional variations in antigen distribution may account for the distinctive distribution of pemphigus lesions.
Chessboard titrations performed by reacting a panel of IC antibodies with a number of skin specimens suggest that there are intercellular antigens of at least two differing specificities in human skin. These can be distinguished by their reactivity with autologous or 346 J-C. Bystryn and J. Rodriguez allogeneic IC antibodies and may represent individual and group-specific antigens, respectively. Either or both of these antigens may be lost in pemphigus foliaceus.
The absence of intercellular antigens in the deep layers of the epidermis may in part account for superficial location of lesions in some patients with pemphigus foliaceus. As a consequence, IC antibodies may only be able to react to superficial antigens, a site which corresponds to the anatomical location of lesions.
We have previously reported that another immune mechanism which may account for superficial lesions in pemphigus foliaceus is subcorneal IC antibodies, which react only to antigens in the superficial layers of the epidermis (22) . Such antibodies are extremely rare in patients without pemphigus foliaceus, having been found in only 0.1% of over 1,000 patients with unrelated skin diseases. Subcorneal IC antibodies were present in one patient in this study. Thus, at least two different mechanisms may account for the location of bullae in the upper layers of the epidermis in pemphigus foliaceus: (a) the presence of IC antibodies directed only to superficial antigens, and (b) the absence of normal deep intercellular antigens. These mechanisms are not mutually exclusive, and either or both may be operative in an individual patient. In both cases, IC antibodies would bind only to the superficial layers of the skin at sites which correspond to, and thus may account for, the superficial locations of lesions in this form of pemphigus.
The ultimate mechanisms producing acantholysis in pemphigus are unknown. Complement activation is suggested by the binding of complement components to the intercellular substance of the epidermis and the presence of reaction products of complement activation in blister fluid of pemphigus lesions (13, 26) . However, our study indicates that there is often a discrepancy between the site of C3 deposition, which is predominantly restricted to the deeper layers ofthe epidermis in pemphigus foliaceus, and that of lesions of the disease, which are always superficial. Furthermore, circulating IC antibodies were unable to fix complement when bound to skin in vitro. These findings, together with the observation that pemphigus serunm can cause acantholysis in vitro in the absence of complement (19) , suggests that complement activation is a result rather than a cause of the initial injury. Viewed in this light, the predominant location of C3 in the deep epidermis might be due to diffusion restraints imposed by the large molecular weight of C3. An alternate mechanism of acantholysis is that binding of intercellular antibodies to the surface of epidermal cells causes activation or release of epidermal proteolytic enzymes (27) or of other factors which in turn lead to acantholysis and activation of complement. Coating of keratinocyte surfaces by intercellular antibodies might also contribute to acantholysis by interfering with the adhesive properties of the cells.
